Jazz Pharmaceuticals plc Operating Lease Right-of-Use Assets
Jazz Pharmaceuticals plc (JAZZ) had Operating Lease Right-of-Use Assets of $52.10 million as of 2026-06-30, per its 10-Q filed 2026-08-03.
Financial Statements › Balance Sheet › Assets › Assets, Noncurrent
us-gaap:OperatingLeaseRightOfUseAsset · last filed 2026-08-03
- 2026-06-30: Operating Lease, Right-of-Use Asset $52.10M.
- 2026-03-31: Operating Lease, Right-of-Use Asset $55.80M.
- 2025-12-31: Operating Lease, Right-of-Use Asset $58.90M; Operating Lease, Right-of-Use Asset as first filed $58.88M.
- 2025-09-30: Operating Lease, Right-of-Use Asset $61.20M.
| Period end | Operating Lease, Right-of-Use Asset | Operating Lease, Right-of-Use Asset as first filed |
|---|---|---|
| 2026-06-30 | $52.10M 10-Q · filed 2026-08-03 | |
| 2026-03-31 | $55.80M 10-Q · filed 2026-05-05 | |
| 2025-12-31 | $58.90M 10-Q · filed 2026-08-03 | $58.88M 10-K · filed 2026-02-24 |
| 2025-09-30 | $61.20M 10-Q · filed 2025-11-05 | |
| 2025-06-30 | $63.08M 10-Q · filed 2025-08-06 | |
| 2025-03-31 | $49.18M 10-Q · filed 2025-05-07 | |
| 2024-12-31 | $53.58M 10-K · filed 2026-02-24 | |
| 2024-09-30 | $77.16M 10-Q · filed 2024-11-07 | |
| 2024-06-30 | $73.14M 10-Q · filed 2024-08-01 | |
| 2024-03-31 | $61.64M 10-Q · filed 2024-05-02 | |
| 2023-12-31 | $65.34M 10-K · filed 2025-02-26 | |
| 2023-09-30 | $65.04M 10-Q · filed 2023-11-08 | |
| 2023-06-30 | $69.04M 10-Q · filed 2023-08-09 | |
| 2023-03-31 | $75.54M 10-Q · filed 2023-05-10 | |
| 2022-12-31 | $73.33M 10-K · filed 2024-02-28 | |
| 2022-09-30 | $73.73M 10-Q · filed 2022-11-09 | |
| 2022-06-30 | $78.36M 10-Q · filed 2022-08-03 | |
| 2022-03-31 | $83.41M 10-Q · filed 2022-05-04 | |
| 2021-12-31 | $86.59M 10-K · filed 2023-03-01 | |
| 2021-09-30 | $89.63M 10-Q · filed 2021-11-09 | |
| 2021-06-30 | $149.25M 10-Q · filed 2021-08-03 | |
| 2021-03-31 | $125.74M 10-Q · filed 2021-05-04 | |
| 2020-12-31 | $129.17M 10-K · filed 2022-03-01 | |
| 2020-09-30 | $130.72M 10-Q · filed 2020-11-02 | |
| 2020-06-30 | $133.18M 10-Q · filed 2020-08-04 | |
| 2020-03-31 | $135.98M 10-Q · filed 2020-05-05 | |
| 2019-12-31 | $139.38M 10-K · filed 2021-02-23 | |
| 2019-09-30 | $141.88M 10-Q · filed 2019-11-05 | |
| 2019-06-30 | $144.75M 10-Q · filed 2019-08-06 | |
| 2019-03-31 | $147.37M 10-Q · filed 2019-05-07 | |
| 2019-01-01 | $149.44M 10-K · filed 2020-02-25 | |
| 2018-12-31 | $0.00 10-Q · filed 2019-11-05 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Summit Therapeutics Inc. (SMMT) | United States | $13.071B | -13.21 |
| BridgeBio Pharma, Inc. (BBIO) | United States | $12.947B | -20.72 |
| CORCEPT THERAPEUTICS INC (CORT) | United States | $12.804B | 169.10 |
| BIOMARIN PHARMACEUTICAL INC (BMRN) | United States | $11.879B | 151.80 |
| MADRIGAL PHARMACEUTICALS, INC. (MDGL) | United States | $11.859B | -38.17 |
| Elanco Animal Health Inc (ELAN) | United States | $11.177B | -61.80 |
| Viatris Inc (VTRS) | United States | $20.008B | -0.00 |
| UNITED THERAPEUTICS Corp (UTHR) | United States | $20.249B | 17.64 |
| Axsome Therapeutics, Inc. (AXSM) | United States | $10.274B | -66.82 |
| ARROWHEAD PHARMACEUTICALS, INC. (ARWR) | United States | $9.331B | -42.28 |